Mark E. Astill
5Patents
4h-index
5Co-inventors
46Inventor score
Filing activity: May 17, 1982 → Nov 5, 1998
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4995402A | Medical droplet whole blood and like monitoring | Emerging Cross-Sectional Technologies | 1,021 | Expired |
| US5047044A | Medical droplet whole blood and like monitoring | Emerging Cross-Sectional Technologies | 482 | Expired |
| US5108889A | Assay for determining analyte using mercury release followed by detection via interaction with aluminum | Emerging Cross-Sectional Technologies | 437 | Expired |
| US4456689A | Competitive protein binding assay using an organosilane-silica gel separation medium | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6238877A | Method for prediction prostate cancer patients' resistance to hormonal treatment by measuring serum concentrations of chromogranin A | Physics | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.